K. Kuno

Successful treatment of an osimertinib-resistant lung adenocarcinoma with an exon 18 EGFR mutation (G719S) with afatinib plus bevacizumab

S. Matsumoto, K. Goto, K. Kunimasa, 2020, Investigational New Drugs.

Switching from first or second generation EGFR-TKI to osimertinib in EGFR mutation-positive NSCLC

K. Kunimasa, F. Imamura, M. Tamiya, 2020, Lung cancer management.

Improvement strategies for successful next-generation sequencing analysis of lung cancer.

S. Matsumoto, K. Goto, K. Kunimasa, 2020, Future oncology.

A case of methotrexate related lymphoproliferative disease difficult to different from lung cancer

J. Uchida, Junpei Takashima, Y. Tanio, 2018 .